Posted by - enderworld -
on - 3 hours ago -
Filed in - Finance -
-
9 Views -
0 Comments -
0 Likes -
0 Reviews
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
